Unformatted text preview: article, the oral form of administering this drug may appeal to many people as the alternative from the current therapy used to treat this disease, which is in the form of needles. The potential side effects of the drug are risk of infection and toxicity of the eyes, liver, lungs and the heart. The article suggests that patients talk to their doctors before switching to the oral form if they are currently using the injection treatment, which has no serious side effects. Within the next couple of weeks, the drug should be ready to be filled for prescriptions. http://voices.washingtonpost.com/checkup/2010/09/fda_approves_first_oral_drug_t.html...
View Full Document
- Spring '10
- autoimmune disease, Novartis International AG